Shopping Cart 0
Cart Subtotal
USD 0

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2019-2026

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 5370

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8995

Details

The global digital therapeutics market was valued at USD 2,238 million in 2018 and is expected to reach USD 9,640 million by 2026 with a CAGR of 19.9% during the forecast period.
Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.
Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.9% from 2019 to 2026. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.
The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 
KEY BENEFITS FOR STAKEHOLDERS
 
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
 
KEY MARKET SEGMENTS
By Application
o Diabetes
o Obesity
o Cardiovascular Disease (CVD)
o Central Nervous System (CNS) Disease
o Respiratory Disease
o Smoking Cessation
o Gastrointestinal Disorder (GID)
o Others
By Product Type
o Software
o Device
By Product Type
o Business-to-Business (B2B)
Employer
Healthcare Provider
Others
o Business-to-Consumer (B2C)
Patient
Caregiver
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
 
READ MORE

Table Of Content

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.4. Research Methodology

 

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools & Models

 

Chapter 2: Executive Summary

 

2.1. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.2.3. Top Player Positioning, 2018

 

3.3. Porter'S Five Forces Analysis

3.4. Market Dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase In Adoption of Smartphones And Tablets Coupled With Healthcare Apps

3.4.1.2. Growth In Need To Control Healthcare Costs

3.4.1.3. Rise In Incidence of Chronic Diseases

 

3.4.2. Restraints

 

3.4.2.1. Lack of Awareness Regarding Digital Therapeutics In Developing Countries

3.4.2.2. Patient Data Privacy Concerns

 

3.4.3. Opportunity

 

3.4.3.1. Emerging Markets offer Significant Growth Opportunities

 

Chapter 4: Digital Therapeutics Market, By Application

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Diabetes

 

4.2.1. Key Market Trends And Growth Opportunities

4.2.2. Market Size And Forecast

4.2.3. Market Analysis, By Country

 

4.3. Obesity

 

4.3.1. Key Market Trends And Growth Opportunities

4.3.2. Market Size And Forecast

4.3.3. Market Analysis, By Country

 

4.4. Cardiovascular Diseases

 

4.4.1. Key Market Trends And Growth Opportunities

4.4.2. Market Size And Forecast

4.4.3. Market Analysis, By Country

 

4.5. Central Nervous System (Cns) Diseases

 

4.5.1. Key Market Trends And Growth Opportunities

4.5.2. Market Size And Forecast

4.5.3. Market Analysis, By Country

 

4.6. Gastrointestinal Disorder

 

4.6.1. Key Market Trends And Growth Opportunities

4.6.2. Market Size And Forecast

4.6.3. Market Analysis, By Country

 

4.7. Respiratory Diseases

 

4.7.1. Key Market Trends And Growth Opportunities

4.7.2. Market Size And Forecast

4.7.3. Market Analysis, By Country

 

4.8. Smoking Cessation

 

4.8.1. Key Market Trends And Growth Opportunities

4.8.2. Market Size And Forecast

4.8.3. Market Analysis, By Country

 

4.9. Others

 

4.9.1. Key Market Trends And Growth Opportunities

4.9.2. Market Size And Forecast

4.9.3. Market Analysis, By Country

 

Chapter 5: Digital Therapeutics Market, By Product

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Software

 

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

 

5.3. Devices

 

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

 

Chapter 6: Digital Therapeutics Market, By Sales Channel

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. Business-To-Business (B2B)

 

6.2.1. Market Size And Forecast, By Type

6.2.2. Employer

 

6.2.2.1. Market Size And Forecast

 

6.2.3. Healthcare Providers

 

6.2.3.1. Market Size And Forecast

 

6.2.4. Others

 

6.2.4.1. Market Size And Forecast

 

6.2.5. Market Size And Forecast, By Region

6.2.6. Market Analysis, By Country

 

6.3. Business-To-Consumers

 

6.3.1. Market Size And Forecast, By Type

6.3.2. Patients

 

6.3.2.1. Market Size And Forecast

 

6.3.3. Caregivers

 

6.3.3.1. Market Size And Forecast

 

6.3.4. Market Size And Forecast, By Region

6.3.5. Market Analysis, By Country

 

Chapter 7: Digital Therapeutics Market, By Region

 

7.1. Overview

 

7.1.1. Market Size And Forecast

 

7.2. North America

 

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. North America Digital Therapeutics Market, By Country

 

7.2.2.1. U.S. Digital Therapeutics Market, By Application

7.2.2.2. U.S Digital Therapeutics Market, By Product Type

7.2.2.3. U.S. Digital Therapeutics Market, By Sales Channel

7.2.2.4. Canada Digital Therapeutics Market, By Application

7.2.2.5. Canada Digital Therapeutics Market, By Product Type

7.2.2.6. Canada Digital Therapeutics Market, By Sales Channel

7.2.2.7. Mexico Digital Therapeutics Market, By Application

7.2.2.8. Mexico Digital Therapeutics Market, By Product Type

7.2.2.9. Mexico Digital Therapeutics Market, By Sales Channel

 

7.2.3. North America Digital Therapeutics Market, By Application

7.2.4. North America Digital Therapeutics Market, By Product Type

7.2.5. North America Digital Therapeutics Market, By Sales Channel

 

7.3. Europe

 

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Europe Digital Therapeutics Market, By Country

 

7.3.2.1. Uk Digital Therapeutics Market, By Application

7.3.2.2. Uk Digital Therapeutics Market, By Product Type

7.3.2.3. Uk Digital Therapeutics Market, By Sales Channel

7.3.2.4. Germany Digital Therapeutics Market, By Application

7.3.2.5. Germany Digital Therapeutics Market, By Product Type

7.3.2.6. Germany Digital Therapeutics Market, By Sales Channel

7.3.2.7. France Digital Therapeutics Market, By Application

7.3.2.8. France Digital Therapeutics Market, By Product Type

7.3.2.9. France Digital Therapeutics Market, By Sales Channel

7.3.2.10. Italy Digital Therapeutics Market, By Application

7.3.2.11. Italy Digital Therapeutics Market, By Product Type

7.3.2.12. Italy Digital Therapeutics Market, By Sales Channel

7.3.2.13. Spain Digital Therapeutics Market, By Application

7.3.2.14. Spain Digital Therapeutics Market, By Product Type

7.3.2.15. Spain Digital Therapeutics Market, By Sales Channel

7.3.2.16. Rest of Europe Digital Therapeutics Market, By Application

7.3.2.17. Rest of Europe Digital Therapeutics Market, By Product Type

7.3.2.18. Rest of Europe Digital Therapeutics Market, By Sales Channel

 

7.3.3. Europe Digital Therapeutics Market, By Application

7.3.4. Europe Digital Therapeutics Market, By Product Type

7.3.5. Europe Digital Therapeutics Market, By Sales Channel

 

7.4. Asia-Pacific

 

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Asia-Pacific Digital Therapeutics Market, By Country

 

7.4.2.1. Japan Digital Therapeutics Market, By Application

7.4.2.2. Japan Digital Therapeutics Market, By Product Type

7.4.2.3. Japan Digital Therapeutics Market, By Sales Channel

7.4.2.4. China Digital Therapeutics Market, By Application

7.4.2.5. China Digital Therapeutics Market, By Product Type

7.4.2.6. China Digital Therapeutics Market, By Sales Channel

7.4.2.7. Australia Digital Therapeutics Market, By Application

7.4.2.8. Australia Digital Therapeutics Market, By Product Type

7.4.2.9. Australia Digital Therapeutics Market, By Sales Channel

7.4.2.10. India Digital Therapeutics Market, By Application

7.4.2.11. India Digital Therapeutics Market, By Product Type

7.4.2.12. India Digital Therapeutics Market, By Sales Channel

7.4.2.13. South Korea Digital Therapeutics Market, By Application

7.4.2.14. South Korea Digital Therapeutics Market, By Product Type

7.4.2.15. South Korea Digital Therapeutics Market, By Sales Channel

7.4.2.16. Rest of Asia-Pacific Digital Therapeutics Market, By Application

7.4.2.17. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type

7.4.2.18. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel

 

7.4.3. Asia-Pacific Digital Therapeutics Market, By Application

7.4.4. Asia-Pacific Digital Therapeutics Market, By Product Type

7.4.5. Asia-Pacific Digital Therapeutics Market, By Sales Channel

 

7.5. Lamea

 

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Lamea Digital Therapeutics Market, By Country

 

7.5.2.1. Brazil Digital Therapeutics Market, By Application

7.5.2.2. Brazil Digital Therapeutics Market, By Product Type

7.5.2.3. Brazil Digital Therapeutics Market, By Sales Channel

7.5.2.4. Turkey Digital Therapeutics Market, By Application

7.5.2.5. Turkey Digital Therapeutics Market, By Product Type

7.5.2.6. Turkey Digital Therapeutics Market, By Sales Channel

7.5.2.7. Saudi Arabia Digital Therapeutics Market, By Application

7.5.2.8. Saudi Arabia Digital Therapeutics Market, By Product Type

7.5.2.9. Saudi Arabia Digital Therapeutics Market, By Sales Channel

7.5.2.10. South Africa Digital Therapeutics Market, By Application

7.5.2.11. South Africa Digital Therapeutics Market, By Product Type

7.5.2.12. South Africa Digital Therapeutics Market, By Sales Channel

7.5.2.13. Rest of Lamea Digital Therapeutics Market, By Application

7.5.2.14. Rest of Lamea Digital Therapeutics Market, By Product Type

7.5.2.15. Rest of Lamea Digital Therapeutics Market, By Sales Channel

 

7.5.3. Lamea Digital Therapeutics Market, By Application

7.5.4. Lamea Digital Therapeutics Market, By Product Type

7.5.5. Lamea Digital Therapeutics Market, By Sales Channel

 

Chapter 8: Company Profiles

 

8.1. 2Morrow, Inc.

 

8.1.1. Company Overview

8.1.2. Company Snapshot

8.1.3. Operating Business Segments

8.1.4. Product Portfolio

8.1.5. Key Strategic Moves And Developments

 

8.2. Fitbit, Inc. (Twine Health, Inc.)

 

8.2.1. Company Overview

8.2.2. Company Snapshot

8.2.3. Product Portfolio

8.2.4. Business Performance

8.2.5. Key Strategic Moves And Developments

 

8.3. Livongo Health, Inc.

 

8.3.1. Company Overview

8.3.2. Company Snapshot

8.3.3. Product Portfolio

8.3.4. Key Strategic Moves And Developments

 

8.4. Medtronic Plc.

 

8.4.1. Company Overview

8.4.2. Company Snapshot

8.4.3. Operating Business Segments

8.4.4. Product Portfolio

8.4.5. Business Performance

8.4.6. Key Strategic Moves And Developments

 

8.5. Omada Health, Inc.

 

8.5.1. Company Overview

8.5.2. Company Snapshot

8.5.3. Key Strategic Moves And Developments

 

8.6. Pear Therapeutics, Inc.

 

8.6.1. Company Overview

8.6.2. Company Snapshot

8.6.3. Product Portfolio

8.6.4. Key Strategic Moves And Developments

 

8.7. Proteus Digital Health, Inc.

 

8.7.1. Company Overview

8.7.2. Company Snapshot

8.7.3. Operating Business Segments

8.7.4. Product Portfolio

8.7.5. Key Strategic Moves And Developments

 

8.8. Resmed, Inc. (Propeller Health)

 

8.8.1. Company Overview

8.8.2. Company Snapshot

8.8.3. Operating Business Segments

8.8.4. Product Portfolio

8.8.5. Business Performance

8.8.6. Key Strategic Moves And Developments

 

8.9. Voluntis, Inc.

 

8.9.1. Company Overview

8.9.2. Company Snapshot

8.9.3. Operating Business Segments

8.9.4. Product Portfolio

8.9.5. Business Performance

8.9.6. Key Strategic Moves And Developments

 

8.10. Welldoc, Inc.

 

8.10.1. Company Overview

8.10.2. Company Snapshot

8.10.3. Operating Business Segments

8.10.4. Product Portfolio

8.10.5. Key Strategic Moves And Developments


List Of Figure

List of Figures

 

Figure 01. Digital Therapeuticss Market Segmentation

Figure 02. Top Investment Pockets In Igital Therapeuticss Market, 2018

Figure 03. Top Winning Strategies, By Year, 2015-2019*

Figure 04. Top Winning Strategies, By Development, 2015-2019* (%)

Figure 05. Top Winning Strategies, By Company, 2015-2019*

Figure 06. Top Player Positioning, 2018

Figure 07. Moderate Bargaining Power of Suppliers

Figure 08. High Bargaining Power of Buyers

Figure 09. Low Threat of Substitution

Figure 10. Moderate Threat of New Entrant

Figure 11. Moderate Competitive Rivalry

Figure 12. Global Digital Therapeutics Market: Restraints, Drivers, And Opportunity

Figure 13. Digital Therapeutics Market By Application

Figure 14. Comparative Analysis of Digital Therapeutics Market For Diabetes, By Country, 2018 & 2026, (USD Million)

Figure 15. Comparative Analysis of Digital Therapeutics Market For Obesity, By Country, 2018 & 2026 (USD Million)

Figure 16. Comparative Analysis of Digital Therapeutics Market For Cardiovascular Diseases, By Country, 2018 & 2026 (USD Million)

Figure 17. Comparative Analysis of Digital Therapeutics Market For Central Nervous System Diseases, By Country, 2018 & 2026 (USD Million)

Figure 18. Comparative Analysis of Digital Therapeutics Market For Gastrointestinal Disorder, By Country, 2018 & 2026 (USD Million)

Figure 19. Comparative Analysis of Digital Therapeutics Market For Respiratory Diseases, By Country, 2018 & 2026 (USD Million)

Figure 20. Comparative Analysis of Digital Therapeutics Market For Smoking Cessation, By Country, 2018 & 2026 (USD Million)

Figure 21. Comparative Analysis of Digital Therapeutics Market For Others, By Country, 2018 & 2026 (USD Million)

Figure 22. Digital Therapeutics Market, By Product

Figure 23. Comparative Share Analysis of Digital Therapeutics Market For Software, By Country, 2017 & 2024 (%)

Figure 24. Comparative Share Analysis of Digital Therapeutics Market For Devices, By Country, 2018 & 2026 (%)

Figure 25. Digital Therapeutics Market By Sales Channel

Figure 26. Digital Therapeutics Market For Business-To-Business Sales Channel, By Employer, 2018-2026 (USD Million)

Figure 27. Digital Therapeutics Market For Business-To-Business Sales Channel, By Healthcare Providers, 2018-2026 (USD Million)

Figure 28. Digital Therapeutics Market For Business-To-Business Sales Channel, By Others, 2018-2026 (USD Million)

Figure 29. Comparative Analysis of Business-To-Business Market, By Country 2018 & 2026 (USD Million)

Figure 30. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Patients, 2018-2026 (USD Million)

Figure 31. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Caregivers, 2018-2026 (USD Million)

Figure 32. Comparative Analysis of Business-To-Consumers, By Country 2018 & 2026 (USD Million)

Figure 33. Fitbit: Net Sales, 2016-2018 (USD Million)

Figure 34. Fitbit: Net Sales By Region, 2018 (%)

Figure 35. Medtronic: Net Sales, 2016-2018 (USD Million)

Figure 36. Medtronic: Revenue Share By Segment, 2018 (%)

Figure 37. Medtronic: Revenue Share By Region, 2018 (%)

Figure 38. Resmed: Net Sales, 2016-2018 (USD Million)

Figure 39. Resmed: Revenue Share By Region, 2018 (%)

Figure 40. Voluntis: Net Sales, 2016-2018 (USD Million)

Figure 41. Voluntis: Revenue Share By Segment, 2018 (%)

Figure 42. Voluntis: Revenue Share By Region, 2018 (%)


List Of Table

List of Tables

 

Table 01. Global Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 02. Digital Therapeutics Market For Diabetes, By Region, 2018-2026 (USD Million)

Table 03. Digital Therapeutics Market For Obesity, By Region, 2018-2026 (USD Million)

Table 04. Digital Therapeutics Market For Cardiovascular Diseases, By Region, 2018-2026 (USD Million)

Table 05. Digital Therapeutics Market For Central Nervous System Diseases, By Region, 2018-2026 (USD Million)

Table 06. Smart Pills For Capsule Endoscopy, Drug Delivery, And Patient Monitoring Available In The Market

Table 07. Digital Therapeutics Market For Gastrointestinal Disorder, By Region, 2018-2026 (USD Million)

Table 08. Digital Therapeutics Market For Respiratory Diseases, By Region, 2018-2026 (USD Million)

Table 09. Digital Therapeutics Market For Smoking Cessation, By Region, 2018-2026 (USD Million)

Table 10. Digital Therapeutics Market For Others, By Region, 2018-2026 (USD Million)

Table 11. Global Digital Therapeutics Market, By Product, 2018-2026 (USD Million)

Table 12. Digital Therapeutic Applications And Software Platforms

Table 13. Global Digital Therapeutics Market For Software, By Region, 2018-2026 (USD Million)

Table 14. Global Digital Therapeutics Market For Devices, By Region, 2018-2026 (USD Million)

Table 15. Global Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 16. Digital Therapeutics Market For Business-To-Business Sales Channel, By Type, 2018-2026 (USD Million)

Table 17. Digital Therapeutics Market For Business-To-Business Sales Channel, By Region, 2018-2026 (USD Million)

Table 18. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Type, 2018-2026 (USD Million)

Table 19. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Region, 2018-2026 (USD Million)

Table 20. Digital Therapeutics Market Revenue, By Region, 2018-2026 (USD Million)

Table 21. North America Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 22. U.S. Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 23. U.S. Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 24. U.S. Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 25. Canada Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 26. Canada Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 27. Canada Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 28. Mexico Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 29. Mexico Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 30. Mexico Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 31. North America Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 32. North America Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 33. North America Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 34. Europe Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 35. Uk Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 36. Uk Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 37. Uk Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 38. Germany Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 39. Germany Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 40. Germany Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 41. France Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 42. France Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 43. France Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 44. Italy Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 45. Italy Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 46. Italy Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 47. Spain Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 48. Spain Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 49. Spain Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 50. Rest of Europe Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 51. Rest of Europe Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 52. Rest of Europe Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 53. Europe Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 54. Europe Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 55. Europe Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 56. Asia-Pacific Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 57. Japan Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 58. Japan Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 59. Japan Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 60. China Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 61. China Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 62. China Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 63. Australia Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 64. Australia Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 65. Australia Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 66. India Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 67. India Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 68. India Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 69. South Korea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 70. South Korea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 71. South Korea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 72. Rest of Asia-Pacific Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 73. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 74. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 75. Asia-Pacific Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 76. Asia-Pacific Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 77. Asia-Pacific Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 78. Lamea Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 79. Brazil Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 80. Brazil Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 81. Brazil Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 82. Turkey Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 83. Turkey Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 84. Turkey Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 85. Saudi Arabia Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 86. Saudi Arabia Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 87. Saudi Arabia Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 88. South Africa Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 89. South Africa Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 90. South Africa Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 91. Rest of Lamea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 92. Rest of Lamea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 93. Rest of Lamea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 94. Lamea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 95. Lamea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 96. Lamea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 97. 2Morrow: Company Snapshot

Table 98. Welldoc: Product Portfolio

Table 99. Fitbit: Company Snapshot

Table 100. Fitbit: Product Portfolio

Table 101. Livongo: Company Snapshot

Table 102. Livongo: Product Portfolio

Table 103. Medtronic: Company Snapshot

Table 104. Medtronic: Operating Segments

Table 105. Medtronic: Product Portfolio

Table 106. Omada: Company Snapshot

Table 107. Pear: Company Snapshot

Table 108. Pear: Product Portfolio

Table 109. Proteus: Company Snapshot

Table 110. Proteus: Product Portfolio

Table 111. Resmed: Company Snapshot

Table 112. Resmed: Operating Segments

Table 113. Resmed: Product Portfolio

Table 114. Voluntis: Company Snapshot

Table 115. Voluntis: Operating Segments

Table 116. Voluntis: Product Portfolio

Table 117. Welldoc: Company Snapshot

Table 118. Welldoc: Product Portfolio

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

2MORROW, Inc., Fitbit, Inc. (Twine Health, Inc.), Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc.

Company Profile

Company Profile Title

The global digital therapeutics market was valued at USD 2,238 million in 2018 and is expected to reach USD 9,640 million by 2026 with a CAGR of 19.9% during the forecast period.
Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.
Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 19.9% from 2019 to 2026. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.
The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
 
KEY BENEFITS FOR STAKEHOLDERS
 
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
 
KEY MARKET SEGMENTS
By Application
o Diabetes
o Obesity
o Cardiovascular Disease (CVD)
o Central Nervous System (CNS) Disease
o Respiratory Disease
o Smoking Cessation
o Gastrointestinal Disorder (GID)
o Others
By Product Type
o Software
o Device
By Product Type
o Business-to-Business (B2B)
Employer
Healthcare Provider
Others
o Business-to-Consumer (B2C)
Patient
Caregiver
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
 
READ MORE

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.4. Research Methodology

 

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools & Models

 

Chapter 2: Executive Summary

 

2.1. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.2.3. Top Player Positioning, 2018

 

3.3. Porter'S Five Forces Analysis

3.4. Market Dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase In Adoption of Smartphones And Tablets Coupled With Healthcare Apps

3.4.1.2. Growth In Need To Control Healthcare Costs

3.4.1.3. Rise In Incidence of Chronic Diseases

 

3.4.2. Restraints

 

3.4.2.1. Lack of Awareness Regarding Digital Therapeutics In Developing Countries

3.4.2.2. Patient Data Privacy Concerns

 

3.4.3. Opportunity

 

3.4.3.1. Emerging Markets offer Significant Growth Opportunities

 

Chapter 4: Digital Therapeutics Market, By Application

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Diabetes

 

4.2.1. Key Market Trends And Growth Opportunities

4.2.2. Market Size And Forecast

4.2.3. Market Analysis, By Country

 

4.3. Obesity

 

4.3.1. Key Market Trends And Growth Opportunities

4.3.2. Market Size And Forecast

4.3.3. Market Analysis, By Country

 

4.4. Cardiovascular Diseases

 

4.4.1. Key Market Trends And Growth Opportunities

4.4.2. Market Size And Forecast

4.4.3. Market Analysis, By Country

 

4.5. Central Nervous System (Cns) Diseases

 

4.5.1. Key Market Trends And Growth Opportunities

4.5.2. Market Size And Forecast

4.5.3. Market Analysis, By Country

 

4.6. Gastrointestinal Disorder

 

4.6.1. Key Market Trends And Growth Opportunities

4.6.2. Market Size And Forecast

4.6.3. Market Analysis, By Country

 

4.7. Respiratory Diseases

 

4.7.1. Key Market Trends And Growth Opportunities

4.7.2. Market Size And Forecast

4.7.3. Market Analysis, By Country

 

4.8. Smoking Cessation

 

4.8.1. Key Market Trends And Growth Opportunities

4.8.2. Market Size And Forecast

4.8.3. Market Analysis, By Country

 

4.9. Others

 

4.9.1. Key Market Trends And Growth Opportunities

4.9.2. Market Size And Forecast

4.9.3. Market Analysis, By Country

 

Chapter 5: Digital Therapeutics Market, By Product

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Software

 

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

 

5.3. Devices

 

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

 

Chapter 6: Digital Therapeutics Market, By Sales Channel

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. Business-To-Business (B2B)

 

6.2.1. Market Size And Forecast, By Type

6.2.2. Employer

 

6.2.2.1. Market Size And Forecast

 

6.2.3. Healthcare Providers

 

6.2.3.1. Market Size And Forecast

 

6.2.4. Others

 

6.2.4.1. Market Size And Forecast

 

6.2.5. Market Size And Forecast, By Region

6.2.6. Market Analysis, By Country

 

6.3. Business-To-Consumers

 

6.3.1. Market Size And Forecast, By Type

6.3.2. Patients

 

6.3.2.1. Market Size And Forecast

 

6.3.3. Caregivers

 

6.3.3.1. Market Size And Forecast

 

6.3.4. Market Size And Forecast, By Region

6.3.5. Market Analysis, By Country

 

Chapter 7: Digital Therapeutics Market, By Region

 

7.1. Overview

 

7.1.1. Market Size And Forecast

 

7.2. North America

 

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. North America Digital Therapeutics Market, By Country

 

7.2.2.1. U.S. Digital Therapeutics Market, By Application

7.2.2.2. U.S Digital Therapeutics Market, By Product Type

7.2.2.3. U.S. Digital Therapeutics Market, By Sales Channel

7.2.2.4. Canada Digital Therapeutics Market, By Application

7.2.2.5. Canada Digital Therapeutics Market, By Product Type

7.2.2.6. Canada Digital Therapeutics Market, By Sales Channel

7.2.2.7. Mexico Digital Therapeutics Market, By Application

7.2.2.8. Mexico Digital Therapeutics Market, By Product Type

7.2.2.9. Mexico Digital Therapeutics Market, By Sales Channel

 

7.2.3. North America Digital Therapeutics Market, By Application

7.2.4. North America Digital Therapeutics Market, By Product Type

7.2.5. North America Digital Therapeutics Market, By Sales Channel

 

7.3. Europe

 

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Europe Digital Therapeutics Market, By Country

 

7.3.2.1. Uk Digital Therapeutics Market, By Application

7.3.2.2. Uk Digital Therapeutics Market, By Product Type

7.3.2.3. Uk Digital Therapeutics Market, By Sales Channel

7.3.2.4. Germany Digital Therapeutics Market, By Application

7.3.2.5. Germany Digital Therapeutics Market, By Product Type

7.3.2.6. Germany Digital Therapeutics Market, By Sales Channel

7.3.2.7. France Digital Therapeutics Market, By Application

7.3.2.8. France Digital Therapeutics Market, By Product Type

7.3.2.9. France Digital Therapeutics Market, By Sales Channel

7.3.2.10. Italy Digital Therapeutics Market, By Application

7.3.2.11. Italy Digital Therapeutics Market, By Product Type

7.3.2.12. Italy Digital Therapeutics Market, By Sales Channel

7.3.2.13. Spain Digital Therapeutics Market, By Application

7.3.2.14. Spain Digital Therapeutics Market, By Product Type

7.3.2.15. Spain Digital Therapeutics Market, By Sales Channel

7.3.2.16. Rest of Europe Digital Therapeutics Market, By Application

7.3.2.17. Rest of Europe Digital Therapeutics Market, By Product Type

7.3.2.18. Rest of Europe Digital Therapeutics Market, By Sales Channel

 

7.3.3. Europe Digital Therapeutics Market, By Application

7.3.4. Europe Digital Therapeutics Market, By Product Type

7.3.5. Europe Digital Therapeutics Market, By Sales Channel

 

7.4. Asia-Pacific

 

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Asia-Pacific Digital Therapeutics Market, By Country

 

7.4.2.1. Japan Digital Therapeutics Market, By Application

7.4.2.2. Japan Digital Therapeutics Market, By Product Type

7.4.2.3. Japan Digital Therapeutics Market, By Sales Channel

7.4.2.4. China Digital Therapeutics Market, By Application

7.4.2.5. China Digital Therapeutics Market, By Product Type

7.4.2.6. China Digital Therapeutics Market, By Sales Channel

7.4.2.7. Australia Digital Therapeutics Market, By Application

7.4.2.8. Australia Digital Therapeutics Market, By Product Type

7.4.2.9. Australia Digital Therapeutics Market, By Sales Channel

7.4.2.10. India Digital Therapeutics Market, By Application

7.4.2.11. India Digital Therapeutics Market, By Product Type

7.4.2.12. India Digital Therapeutics Market, By Sales Channel

7.4.2.13. South Korea Digital Therapeutics Market, By Application

7.4.2.14. South Korea Digital Therapeutics Market, By Product Type

7.4.2.15. South Korea Digital Therapeutics Market, By Sales Channel

7.4.2.16. Rest of Asia-Pacific Digital Therapeutics Market, By Application

7.4.2.17. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type

7.4.2.18. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel

 

7.4.3. Asia-Pacific Digital Therapeutics Market, By Application

7.4.4. Asia-Pacific Digital Therapeutics Market, By Product Type

7.4.5. Asia-Pacific Digital Therapeutics Market, By Sales Channel

 

7.5. Lamea

 

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Lamea Digital Therapeutics Market, By Country

 

7.5.2.1. Brazil Digital Therapeutics Market, By Application

7.5.2.2. Brazil Digital Therapeutics Market, By Product Type

7.5.2.3. Brazil Digital Therapeutics Market, By Sales Channel

7.5.2.4. Turkey Digital Therapeutics Market, By Application

7.5.2.5. Turkey Digital Therapeutics Market, By Product Type

7.5.2.6. Turkey Digital Therapeutics Market, By Sales Channel

7.5.2.7. Saudi Arabia Digital Therapeutics Market, By Application

7.5.2.8. Saudi Arabia Digital Therapeutics Market, By Product Type

7.5.2.9. Saudi Arabia Digital Therapeutics Market, By Sales Channel

7.5.2.10. South Africa Digital Therapeutics Market, By Application

7.5.2.11. South Africa Digital Therapeutics Market, By Product Type

7.5.2.12. South Africa Digital Therapeutics Market, By Sales Channel

7.5.2.13. Rest of Lamea Digital Therapeutics Market, By Application

7.5.2.14. Rest of Lamea Digital Therapeutics Market, By Product Type

7.5.2.15. Rest of Lamea Digital Therapeutics Market, By Sales Channel

 

7.5.3. Lamea Digital Therapeutics Market, By Application

7.5.4. Lamea Digital Therapeutics Market, By Product Type

7.5.5. Lamea Digital Therapeutics Market, By Sales Channel

 

Chapter 8: Company Profiles

 

8.1. 2Morrow, Inc.

 

8.1.1. Company Overview

8.1.2. Company Snapshot

8.1.3. Operating Business Segments

8.1.4. Product Portfolio

8.1.5. Key Strategic Moves And Developments

 

8.2. Fitbit, Inc. (Twine Health, Inc.)

 

8.2.1. Company Overview

8.2.2. Company Snapshot

8.2.3. Product Portfolio

8.2.4. Business Performance

8.2.5. Key Strategic Moves And Developments

 

8.3. Livongo Health, Inc.

 

8.3.1. Company Overview

8.3.2. Company Snapshot

8.3.3. Product Portfolio

8.3.4. Key Strategic Moves And Developments

 

8.4. Medtronic Plc.

 

8.4.1. Company Overview

8.4.2. Company Snapshot

8.4.3. Operating Business Segments

8.4.4. Product Portfolio

8.4.5. Business Performance

8.4.6. Key Strategic Moves And Developments

 

8.5. Omada Health, Inc.

 

8.5.1. Company Overview

8.5.2. Company Snapshot

8.5.3. Key Strategic Moves And Developments

 

8.6. Pear Therapeutics, Inc.

 

8.6.1. Company Overview

8.6.2. Company Snapshot

8.6.3. Product Portfolio

8.6.4. Key Strategic Moves And Developments

 

8.7. Proteus Digital Health, Inc.

 

8.7.1. Company Overview

8.7.2. Company Snapshot

8.7.3. Operating Business Segments

8.7.4. Product Portfolio

8.7.5. Key Strategic Moves And Developments

 

8.8. Resmed, Inc. (Propeller Health)

 

8.8.1. Company Overview

8.8.2. Company Snapshot

8.8.3. Operating Business Segments

8.8.4. Product Portfolio

8.8.5. Business Performance

8.8.6. Key Strategic Moves And Developments

 

8.9. Voluntis, Inc.

 

8.9.1. Company Overview

8.9.2. Company Snapshot

8.9.3. Operating Business Segments

8.9.4. Product Portfolio

8.9.5. Business Performance

8.9.6. Key Strategic Moves And Developments

 

8.10. Welldoc, Inc.

 

8.10.1. Company Overview

8.10.2. Company Snapshot

8.10.3. Operating Business Segments

8.10.4. Product Portfolio

8.10.5. Key Strategic Moves And Developments


List Of Figure

List of Figures

 

Figure 01. Digital Therapeuticss Market Segmentation

Figure 02. Top Investment Pockets In Igital Therapeuticss Market, 2018

Figure 03. Top Winning Strategies, By Year, 2015-2019*

Figure 04. Top Winning Strategies, By Development, 2015-2019* (%)

Figure 05. Top Winning Strategies, By Company, 2015-2019*

Figure 06. Top Player Positioning, 2018

Figure 07. Moderate Bargaining Power of Suppliers

Figure 08. High Bargaining Power of Buyers

Figure 09. Low Threat of Substitution

Figure 10. Moderate Threat of New Entrant

Figure 11. Moderate Competitive Rivalry

Figure 12. Global Digital Therapeutics Market: Restraints, Drivers, And Opportunity

Figure 13. Digital Therapeutics Market By Application

Figure 14. Comparative Analysis of Digital Therapeutics Market For Diabetes, By Country, 2018 & 2026, (USD Million)

Figure 15. Comparative Analysis of Digital Therapeutics Market For Obesity, By Country, 2018 & 2026 (USD Million)

Figure 16. Comparative Analysis of Digital Therapeutics Market For Cardiovascular Diseases, By Country, 2018 & 2026 (USD Million)

Figure 17. Comparative Analysis of Digital Therapeutics Market For Central Nervous System Diseases, By Country, 2018 & 2026 (USD Million)

Figure 18. Comparative Analysis of Digital Therapeutics Market For Gastrointestinal Disorder, By Country, 2018 & 2026 (USD Million)

Figure 19. Comparative Analysis of Digital Therapeutics Market For Respiratory Diseases, By Country, 2018 & 2026 (USD Million)

Figure 20. Comparative Analysis of Digital Therapeutics Market For Smoking Cessation, By Country, 2018 & 2026 (USD Million)

Figure 21. Comparative Analysis of Digital Therapeutics Market For Others, By Country, 2018 & 2026 (USD Million)

Figure 22. Digital Therapeutics Market, By Product

Figure 23. Comparative Share Analysis of Digital Therapeutics Market For Software, By Country, 2017 & 2024 (%)

Figure 24. Comparative Share Analysis of Digital Therapeutics Market For Devices, By Country, 2018 & 2026 (%)

Figure 25. Digital Therapeutics Market By Sales Channel

Figure 26. Digital Therapeutics Market For Business-To-Business Sales Channel, By Employer, 2018-2026 (USD Million)

Figure 27. Digital Therapeutics Market For Business-To-Business Sales Channel, By Healthcare Providers, 2018-2026 (USD Million)

Figure 28. Digital Therapeutics Market For Business-To-Business Sales Channel, By Others, 2018-2026 (USD Million)

Figure 29. Comparative Analysis of Business-To-Business Market, By Country 2018 & 2026 (USD Million)

Figure 30. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Patients, 2018-2026 (USD Million)

Figure 31. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Caregivers, 2018-2026 (USD Million)

Figure 32. Comparative Analysis of Business-To-Consumers, By Country 2018 & 2026 (USD Million)

Figure 33. Fitbit: Net Sales, 2016-2018 (USD Million)

Figure 34. Fitbit: Net Sales By Region, 2018 (%)

Figure 35. Medtronic: Net Sales, 2016-2018 (USD Million)

Figure 36. Medtronic: Revenue Share By Segment, 2018 (%)

Figure 37. Medtronic: Revenue Share By Region, 2018 (%)

Figure 38. Resmed: Net Sales, 2016-2018 (USD Million)

Figure 39. Resmed: Revenue Share By Region, 2018 (%)

Figure 40. Voluntis: Net Sales, 2016-2018 (USD Million)

Figure 41. Voluntis: Revenue Share By Segment, 2018 (%)

Figure 42. Voluntis: Revenue Share By Region, 2018 (%)


List Of Table

List of Tables

 

Table 01. Global Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 02. Digital Therapeutics Market For Diabetes, By Region, 2018-2026 (USD Million)

Table 03. Digital Therapeutics Market For Obesity, By Region, 2018-2026 (USD Million)

Table 04. Digital Therapeutics Market For Cardiovascular Diseases, By Region, 2018-2026 (USD Million)

Table 05. Digital Therapeutics Market For Central Nervous System Diseases, By Region, 2018-2026 (USD Million)

Table 06. Smart Pills For Capsule Endoscopy, Drug Delivery, And Patient Monitoring Available In The Market

Table 07. Digital Therapeutics Market For Gastrointestinal Disorder, By Region, 2018-2026 (USD Million)

Table 08. Digital Therapeutics Market For Respiratory Diseases, By Region, 2018-2026 (USD Million)

Table 09. Digital Therapeutics Market For Smoking Cessation, By Region, 2018-2026 (USD Million)

Table 10. Digital Therapeutics Market For Others, By Region, 2018-2026 (USD Million)

Table 11. Global Digital Therapeutics Market, By Product, 2018-2026 (USD Million)

Table 12. Digital Therapeutic Applications And Software Platforms

Table 13. Global Digital Therapeutics Market For Software, By Region, 2018-2026 (USD Million)

Table 14. Global Digital Therapeutics Market For Devices, By Region, 2018-2026 (USD Million)

Table 15. Global Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 16. Digital Therapeutics Market For Business-To-Business Sales Channel, By Type, 2018-2026 (USD Million)

Table 17. Digital Therapeutics Market For Business-To-Business Sales Channel, By Region, 2018-2026 (USD Million)

Table 18. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Type, 2018-2026 (USD Million)

Table 19. Digital Therapeutics Market For Business-To-Consumers Sales Channel, By Region, 2018-2026 (USD Million)

Table 20. Digital Therapeutics Market Revenue, By Region, 2018-2026 (USD Million)

Table 21. North America Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 22. U.S. Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 23. U.S. Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 24. U.S. Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 25. Canada Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 26. Canada Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 27. Canada Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 28. Mexico Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 29. Mexico Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 30. Mexico Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 31. North America Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 32. North America Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 33. North America Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 34. Europe Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 35. Uk Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 36. Uk Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 37. Uk Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 38. Germany Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 39. Germany Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 40. Germany Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 41. France Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 42. France Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 43. France Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 44. Italy Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 45. Italy Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 46. Italy Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 47. Spain Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 48. Spain Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 49. Spain Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 50. Rest of Europe Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 51. Rest of Europe Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 52. Rest of Europe Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 53. Europe Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 54. Europe Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 55. Europe Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 56. Asia-Pacific Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 57. Japan Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 58. Japan Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 59. Japan Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 60. China Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 61. China Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 62. China Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 63. Australia Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 64. Australia Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 65. Australia Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 66. India Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 67. India Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 68. India Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 69. South Korea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 70. South Korea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 71. South Korea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 72. Rest of Asia-Pacific Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 73. Rest of Asia-Pacific Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 74. Rest of Asia-Pacific Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 75. Asia-Pacific Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 76. Asia-Pacific Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 77. Asia-Pacific Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 78. Lamea Digital Therapeutics Market, By Country, 2018-2026 (USD Million)

Table 79. Brazil Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 80. Brazil Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 81. Brazil Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 82. Turkey Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 83. Turkey Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 84. Turkey Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 85. Saudi Arabia Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 86. Saudi Arabia Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 87. Saudi Arabia Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 88. South Africa Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 89. South Africa Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 90. South Africa Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 91. Rest of Lamea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 92. Rest of Lamea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 93. Rest of Lamea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 94. Lamea Digital Therapeutics Market, By Application, 2018-2026 (USD Million)

Table 95. Lamea Digital Therapeutics Market, By Product Type, 2018-2026 (USD Million)

Table 96. Lamea Digital Therapeutics Market, By Sales Channel, 2018-2026 (USD Million)

Table 97. 2Morrow: Company Snapshot

Table 98. Welldoc: Product Portfolio

Table 99. Fitbit: Company Snapshot

Table 100. Fitbit: Product Portfolio

Table 101. Livongo: Company Snapshot

Table 102. Livongo: Product Portfolio

Table 103. Medtronic: Company Snapshot

Table 104. Medtronic: Operating Segments

Table 105. Medtronic: Product Portfolio

Table 106. Omada: Company Snapshot

Table 107. Pear: Company Snapshot

Table 108. Pear: Product Portfolio

Table 109. Proteus: Company Snapshot

Table 110. Proteus: Product Portfolio

Table 111. Resmed: Company Snapshot

Table 112. Resmed: Operating Segments

Table 113. Resmed: Product Portfolio

Table 114. Voluntis: Company Snapshot

Table 115. Voluntis: Operating Segments

Table 116. Voluntis: Product Portfolio

Table 117. Welldoc: Company Snapshot

Table 118. Welldoc: Product Portfolio

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

2MORROW, Inc., Fitbit, Inc. (Twine Health, Inc.), Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc.